INBX - Inhibrx Biosciences Inc.
130.665
-0.785 -0.601%
Share volume: 379,225
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$131.45
-0.78
-0.01%
Summary score
42%
Profitability
50%
Dept financing
39%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.95%
Return on assets
33.68%
Return on sales
-70199.24%
Return on invested capital
233.33%
Total debt ratio
75.7%
Debt ratio change over timeo
-0.64%
Current Ratio
6.18%
Quick Ratio
7.15%
Cash Position Ratio
5.88%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-19.31%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
78.29%
Debt ratio change over timeo
0%
Current Ratio
4.51%
Quick Ratio
0%
Cash Position Ratio
4.3%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-21.14%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
94.54%
Debt ratio change over time
0%
Current Ratio
3.93%
Quick Ratio
0%
Cash Position Ratio
3.68%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-132.49%
Return on assets
-48.42%
Return on sales
-40224.73%
Return on invested capital
-9.68%
Total debt ratio
-63.96%
Debt ratio change over time
-0.64%
Current Ratio
2.13%
Quick Ratio
1.95%
Cash Position Ratio
1.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INBX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -42.95% | 0% | 5.97% | 8.91% |
| Return on assets | 33.68% | 2.97% | 3.34% | 2.04% |
| Return on sales | -70199.24% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 233.33% | 0% | 3.51% | 10.25% |
| Profitability | 50% | 27% | 45% | 47% |
| Total debt ratio | 75.7% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -0.64% | 14.34% | 187.33% | 9.75% |
| Dept financing | 20% | 27% | 43% | 13% |
| Current Ratio | 4.51% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 4.3% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 15% | 12% | 18% |
| Short-term ratios | INBX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -19.31% | 3.27% | 4.7% | 1.36% |
| Return on sales | 0% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 78.29% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 46% | 25% | 18% | 10% |
| Current Ratio | 4.51% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 4.3% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 23% | 30% | 43% |